Table 2.
Gluten Ataxia | Anti-GAD65 Ab-associated Cerebellar Ataxia | |
---|---|---|
Clinical profile | ||
Time course | Insidious and chronic | Insidious and chronic or subacute |
Age and sex | 50s, female (55%) | 60s, female (mostly) |
Main symptoms of cerebellar involvement |
Gait ataxia. Limb ataxia and nystagmus are mild and less frequent (60-70%) | Gait ataxia. Limb ataxia and nystagmus are mild and less frequent (60-70%) |
Associated neurological symptoms | Cortical myoclonus, neuropathy | Stiff person syndrome, epilepsy |
Abnormality in cerebrospinal fluid | Generally none | Sometimes; CSF oligoclonal bands |
Cerebellar atrophy on MRI | Present depending on duration of ataxia. The vermis is primarily involved. The degree of atrophy is mild relative to ataxia |
Present depending on duration of ataxia The vermis is primarily involved. The degree of atrophy is mild relative to ataxia |
Clues for diagnosis Neurological features suggestive the need for further investigations on autoimmunity: • 40-60s, female • Gait ataxia with dominant vermian atrophy • Atrophy on MRI is milder relative to the severity of ataxia | ||
Gluten Ataxia | Anti-GAD65Ab-associated Cerebellar Ataxia | |
Autoimmune background | ||
Trigger of autoimmunity | Gluten ingestion | Unknown |
HLA | Type DQ2 or DQ8 | - |
Well characterized autoantibodies | Anti-gliadin (IgG/IgA) Anti-TG2, TG6 |
Anti-GAD65Ab (high titer) usually exceeds the levels seen in type 1 diabetes mellitus by 100-fold |
Associated autoimmune diseases | Coeliac disease (47%) | Type 1 diabetes mellitus, autoimmune thyroid diseases, pernicious anemia |